Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator.
Circulation., Nov;126(20):2402-7 (2012)
Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry.
Pacing Clin Electrophysiol., Jan;35(1):81-7 (2012)
Shocks: the whole truth, the partial truth, or nowhere near the truth.
Circ Arrhythm Electrophysiol., Aug;4(4):424-5 (2011)
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this d
Heart Rhythm., Jul;8(7):1114-54 (2011)
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management: execu
Heart Rhythm., Jul;8(7):e1-18 (2011)
ICD implantation and evidence-based patient selection.
JAMA., Apr;305(15):1537; author reply 1539-40 (2011)
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Heart Rhythm., Mar;8(3):393-400 (2011)
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
Circulation., Oct;122(16):1553-61 (2010)
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial.
Heart Rhythm., Jan;8(1):38-45 (2011)
More about pacemakers.
J Am Dent Assoc., Sep;141(9):1053; author reply 1053-4 (2010)
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT).
Am. Heart J., Apr;159(4):627-634.e7 (2010)
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Circulation., Dec;120(22):2170-6 (2009)
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.
Circulation., Sep;120(10):835-42 (2009)
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Am. Heart J., Dec;156(6):1196-200 (2008)
Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.
Circulation., Nov;118(20):2022-8 (2008)
Prognostic importance of defibrillator shocks in patients with heart failure.
N. Engl. J. Med., Sep;359(10):1009-17 (2008)
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
J. Am. Coll. Cardiol., Aug;52(7):551-6 (2008)
Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
J. Cardiovasc. Electrophysiol., Oct;19(10):1059-65 (2008)
Not the usual cardiac rhythm device infection: a fastidious pathogen with several teaching points.
J Hosp Med., Mar;3(2):173-5 (2008)
Home use of automated external defibrillators for sudden cardiac arrest.
N. Engl. J. Med., Apr;358(17):1793-804 (2008)